substance misuse

Pear Therapeutics, Novartis announce commercial launch of reSET
By Dave Muoio | 04:35 pm | November 20, 2018
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.